It is primarily available for research purposes, and its use in humans carries regulatory and safety considerations
Furthermore, they slow down gastric emptying, meaning that food and liquids stay in your stomach for a longer period, which also slows digestion
According to our results, individuals treated with GLP-1RA were the least persistent at 2 years among the four groups examined, including comparisons to both oral agent and insulin users, which is in agreement with previous studies [17,18,19]
We're pleased to get your Inquiry and we will reply you as soon as possible
**Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program